Mirabegron 70771-1752-03

Package NDC

70771-1752-03

Manufacturer: Zydus Lifesciences Limited
Dosage Form: Tablet, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: January 23, 2024
Listing Expires: December 31, 2026
Application: ANDA209488

Need to source Mirabegron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Mirabegron	25 mg/1

Drug Class

beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]

Selected Package

70771-1752-03Selected

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-3)

Other packages for this product(2)

70771-1752-01

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-1)

View →

70771-1752-09

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-9)

View →